Pasithea Therapeutics Corp. (KTTAW) Notes Payables (2022 - 2023)

Pasithea Therapeutics has disclosed Notes Payables across 2 years of filings, most recently posting $133335.0 for Q2 2023.

• In Q2 2023, Notes Payables changed N/A year-over-year to $133335.0; the TTM figure through Jun 2023 stood at $133335.0 (changed N/A YoY), while the FY2022 annual figure was $8611.0, changed N/A from the prior year.
• Notes Payables came in at $133335.0 for Q2 2023 at Pasithea Therapeutics, down from $264103.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $264103.0 in Q1 2023 to a low of $8611.0 in Q4 2022.